Home  >  News
News
  Patanjali ties up with 1mg to push online sales to expand the reach to customers,   January 16, 2018
  MyMedicineBox launches nationwide vitamin-D deficiency awareness campaign,   January 16, 2018
  Medlife forays into North-East India to cater to 90% pan-India market by year end,   January 16, 2018
  Sentech Corp to distribute US Diagnostics' Infinity Blood Glucose Monitoring System in Western Africa,   January 16, 2018
  Nuvo Ireland buys US rights to Resultz from Piedmont Pharma,   January 16, 2018
  CGT Catapult, CombiGene ink collaboration to develop manufacturing process for novel gene therapy to treat epilepsy,   January 16, 2018
  Hikma Pharma appoints Dr Surendera Tyagi as group CSO & global head of R&D,   January 16, 2018
  SEMCO aswarded SBIR phase 1 NCI contract to study its lead molecules in preclinical model of triple negative breast cancer,   January 16, 2018
  No longer the future of medicine, gene therapy is part of present-day clinical treatment: Study,   January 16, 2018
  Mundipharma to market Grünenthal’s pain drug, Tramal in China,   January 16, 2018
  Norgine receives Austrian, French, Irish, Italian & Portuguese regulatory approval for Plenvu for bowel cleansing in adults,   January 16, 2018
  Study shows steep increase in rate of alcohol-related ER visits,   January 15, 2018
  Lupin forays into OTC segment with Softovac,   January 15, 2018
  Dynasil submits Xcede Technologies' application for first-in-human trial,   January 15, 2018
  People with intellectual disability cannot donate organs even to their kin,   January 15, 2018
  J&J India joins forces with govt of Maharashtra to boost public health in the state,   January 15, 2018
  US FDA approves Lynparza to treat patients with germline BRCA-mutated metastatic breast cancer,   January 15, 2018
  Glenmark receives DCGI nod to start phase IIb dose range study of GRC 27864 to treat osteoarthritic pain,   January 15, 2018
  USC opens applications for new hybrid doctor of physical therapy programme,   January 15, 2018
  MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial,   January 15, 2018

 Back
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |